Skip to content

Daily vs. weekly showering in atopic dermatitis: a randomized controlled clinical trial.

Daily vs. weekly showering in atopic dermatitis: a randomized controlled clinical trial. - WATER study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42004
Enrollment
46
Registered
2015-04-10
Start date
2015-07-09
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis atopic eczema

Interventions

Each patient is assigned a randomization number according to a computer generated randomization. Randomization will be performed with a 1:1 allocation. One group will shower once daily every day acc
the other group will shower once weekly according to a standard protocol for 4 weeks. All patients will use emollients daily and will be allowed to continue topical medication (except tar ointments)
atopic dermatitis
water

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Male or female patients with atopic dermatitis (AD) according to the UK working party criteria Age 4-12 years Mild to moderate AD (objective SCORAD

Exclusion criteria

Exclusion criteria: Active skin infection requiring antibiotic treatment Systemic immunomodulatory treatment (for AD or other diseases) Intolerance to Vaseline paraffin ANA Unwillingness to use Vaseline paraffin ANA as sole emollient Usage of tar ointments Usage of thin bleach baths Performance of water sports (swimming etc) more than once a week

Design outcomes

Primary

MeasureTime frame
Comparison of change in objective SCORAD from week 4 compared to week 0 between procedure groups.

Secondary

MeasureTime frame
Comparison of change in Eczema Area and Severity Index (EASI), quality of life, AD symptoms, transepidermal water loss, skin capacitance, natural moisturizing factors and skin lipids in tape strips at week 4 compared to week 0 between procedure groups. Used amounts of topical medication and Vaseline paraffin ANA and patient*s preference for once weekly vs daily showering at week 4 will be compared between procedure groups. The change in objective SCORAD from week 4 compared to week 0 will be compared between procedure groups, stratified by mild vs moderate AD, and stratified by light skin types (1, 2, 3) vs dark skin types (4, 5, 6).

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)